Navigation Links
GenVault Corporation to Present at the 2009 BIOCOM Investor Conference
Date:10/24/2009

CARLSBAD, Calif., Oct. 23 /PRNewswire/ -- GenVault Corporation, the leader in ambient temperature biosample management for genomic discovery, medicine and identification, today announced that David Wellis, Ph.D., GenVault's President and CEO, will be presenting at the BIOCOM Investor Conference taking place on October 26th and 27th in La Jolla, CA.

During the presentation, Dr. Wellis will provide an overview of the company together with recent customer, technical and strategic developments that have enabled GenVault to target the broader life sciences transport and storage markets. The major advantages of GenVault's technologies are the reduction of cost, waste and complexity associated with traditional biosample management in the academic and commercial sectors of the life sciences marketplace.

The following are specific details of GenVault's presentation at the conference:

BIOCOM Investor Conference

Date: Monday, October 26th, 2009

Time: 4:00pm (Track 2)

Location: Hyatt Regency La Jolla

Room: Aventine Ballroom, Room B

About GenVault

GenVault is the global leader in providing risk free biosample workflow, transport, and storage solutions for genomic medicine, discovery and identification. Today, GenVault is empowering pharmaceutical companies, medical centers, academic institutions and law enforcement agencies to more fully leverage the rapidly growing genomics industry. As a scalable, reliable and environmentally friendly alternative to traditional freezers and DNA purification systems, the company's dry-state platform enables the extraction, preservation, recovery, and distribution of biosamples at ambient temperature. Future systems will also accommodate proteins and RNA to provide a comprehensive solution. From GenPlates to the Dynamic Archive, GenVault is continuously developing and refining best practices biosample management and preservation. For more information visit GenVault at www.genvault.com.

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.

Bret Dash

http://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=87941

    BUSINESS CONTACT:
    Bret Dash
    Director of Marketing
    (760) 717-3774
    bdash@genvault.com

SOURCE GenVault Corporation


'/>"/>
SOURCE GenVault Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related biology news :

1. Harris Corporation Adds Broadband Satellite Data Mode to JTRS-Approved Falcon III(R) AN/PRC-117G Multiband Manpack Radio
2. M2SYS Biometric Software Solution Selected By GHG Corporation
3. delSECUR CORPORATION Announces Agreement to Purchase the Intellectual Property Assets of the Corporation
4. delSECUR CORPORATION Announces Agreement to Purchase the Intellectual Property Assets of the Corporation
5. $29.4 million grant establishes CTSI at NYU in partnership with Health and Hospitals Corporation
6. delSECUR CORPORATION Announces Appointment of the Companys President & CEO
7. CEL-SCI Corporation to Launch Aseptic Filling for Stem Cell Produced Therapies and Other Biological Products
8. Communication Intelligence Corporation Reports Fourth Quarter and Fiscal 2008 Results
9. Communication Intelligence Corporation Reports Third Quarter 2008 Financial Results
10. Carbon Disclosure Project: Worlds largest corporations seek clarity on climate change regulation
11. L-1 Identity Solutions Completes Acquisition of the ID Systems Business from Digimarc Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2016)... 23, 2016 Cercacor today introduced Ember TM ... trainers non-invasively measure hemoglobin, Oxygen Content, Oxygen ... Respiration Rate in approximately 30 seconds. Smaller than a ... immediate access to key data about their bodies to ... regimen. Hemoglobin carries oxygen to muscles. ...
(Date:11/17/2016)... Global Market Watch: Primarily supported by ... Banks and Academics) market is to witness a value of ... the highest Compounded Annual Growth Rate (CAGR) of 10.75% is ... analysis period 2014-2020. North America is ... Europe at 9.56% respectively. Report ...
(Date:11/14/2016)... Technology, Inc. ("xG" or the "Company") (Nasdaq: XGTI, XGTIW), ... in challenging operating environments, announced its results for the ... a conference call to discuss these results on November ... Key Recent Accomplishments ... acquire Vislink Communication Systems. The purchase is expected to ...
Breaking Biology News(10 mins):
(Date:12/2/2016)... PUNE, India , December 2, 2016 ... Billion by 2021, growing at a CAGR of 7.3% during the ... segment while hospitals and diagnostic laboratories segment accounted for the largest ... ... Complete report on global immunohistochemistry (IHC) market spread across 225 ...
(Date:11/30/2016)... , Nov. 30, 2016  GenomOncology today announced the appointment ... of Medical Affairs.  Dr. Coleman will oversee ... company,s proprietary knowledge-enabled platform. The GenomOncology software suite empowers molecular ... sequencing data and clinical decision support, from quality control through ... , , ...
(Date:11/30/2016)... RATON, Fla. , Nov. 30, 2016 ... biotherapeutic products, is pleased to announce the addition of ... Avenue Kearney, Nebraska . The 15,200 ... business on November 29th, 2016 and brings the total ... Ileana Carlisle , BPC,s Chief Executive ...
(Date:11/30/2016)... 30, 2016  Tempus, a technology company focused ... Penn,s Abramson Cancer Center have partnered to better ... to immunotherapy treatment based on next generation genomic ... of a research collaboration, Tempus will provide sequencing ... patient data to Penn. Utilizing next-generation sequencing, machine ...
Breaking Biology Technology: